Zoetis has made a pair of changes to its leadership team, giving its chief financial officer a new role as group president and hiring a new CFO, it announced Tuesday.
The Parsippany-based animal health company said in a news release that Glenn David, executive vice president and CFO, has been named EVP and group president, overseeing international operations and other business units, effective June 1.
“Glenn’s record of success at Zoetis, plus his deep knowledge of our operations and the animal health industry, make him the ideal leader to drive Zoetis’ next phase of global growth in international markets, aquaculture, biodevices and pet insurance,” CEO Kristin Peck said in a prepared statement. “As CFO for the last five years and a leader in animal health for a decade, Glenn has been a champion for building our business.”
In addition, Wetteny Joseph has joined the company as EVP and CFO, overseeing the company’s financial management, planning and business development group, also effective June 1.
“The board and I are also excited to welcome Wetteny, a proven leader in health care whose global experience and results-driven approach will help ensure that Zoetis continues its strong growth trajectory,” Peck said. “Wetteny has impeccable CFO credentials from his years at Catalent, and he has built world-class finance organizations and strong relationships with the investment community.”
As group president, David will oversee Zoetis’ international operations, including in two of the company’s largest and fastest-growing markets, China and Brazil, among other responsibilities. He has been CFO since 2016, and served as senior VP of finance operations for the company during its initial public offering and spinoff from Pfizer — where he had served in various executive roles.
“I am very proud of what we have accomplished at Zoetis over the last eight years, and I see even greater opportunities ahead with an innovative portfolio that is addressing critical needs and defining new standards of care for animals,” he said in a statement. “I am excited to take on a more customer-facing role leading our commercial teams, and I look forward to helping accelerate our long-term growth in international markets, where we see untapped opportunities for our products and services.”
Joseph joins Zoetis from Somerset-based drug delivery technology company Catalent, where he had spent the past 13 years, most recently serving as SVP and CFO since 2018. He joins the Zoetis Executive Team and will report directly to Peck.
“I am delighted with the tremendous opportunity to join a world-leading company like Zoetis,” he said in a statement. “Zoetis has been delivering sustainable revenue and earnings growth since its launch, while also introducing innovative new products for customers. I look forward to bringing my skills and experience to Zoetis and building on that strong track record of performance.”
Both David and Joseph will work out of the Parsippany headquarters, Zoetis said.
Catalent’s CFO succession plan
Catalent, meanwhile, announced that Thomas Castellano, its global vice president of operational finance, will succeed Joseph as its SVP and CFO, effective June 1.
“On behalf of the board, our shareholders and all of us at Catalent, we’d like to thank Wetteny for his long and dedicated service, and we wish him every success in his future endeavors,” Chair and CEO John Chiminski said in a statement. “We are delighted to recognize Tom’s continuing contributions and development as a senior executive at Catalent, and I look forward to working with him in his new role. Today’s smooth succession demonstrates the strength of Catalent’s bench and our proactive planning and executive development efforts.”
